-
公开(公告)号:US20130039938A1
公开(公告)日:2013-02-14
申请号:US13280043
申请日:2011-10-24
申请人: Gale SMITH , Yingyun Wu , Michael Massare , Peter Pushko , Margret Nathan , Thomas Kort , Robin Robinson
发明人: Gale SMITH , Yingyun Wu , Michael Massare , Peter Pushko , Margret Nathan , Thomas Kort , Robin Robinson
IPC分类号: A61K39/145 , C12P21/02 , C12N9/24 , C07K14/11 , A61P37/04
CPC分类号: C12N7/00 , A61K39/12 , A61K2039/5258 , A61K2039/55505 , A61K2039/55555 , C07K14/005 , C07K2319/01 , C07K2319/03 , C12N9/2402 , C12N2710/14143 , C12N2760/16122 , C12N2760/16123 , C12N2760/16134 , C12N2760/16151 , C12N2760/16171 , C12N2760/16222 , C12N2760/16223 , C12N2760/16251 , C12N2770/20022 , C12N2770/20023 , C12N2770/20051 , C12N2800/22 , C12Y302/01018
摘要: This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
-
公开(公告)号:US20130122032A1
公开(公告)日:2013-05-16
申请号:US13629107
申请日:2012-09-27
申请人: Gale SMITH , Yingyun Wu , Michael Massare , Ye Liu
发明人: Gale SMITH , Yingyun Wu , Michael Massare , Ye Liu
IPC分类号: C07K14/135 , A61K39/155
CPC分类号: A61K39/155 , A61K39/12 , A61K2039/5258 , A61K2039/54 , A61K2039/55505 , A61K2039/55555 , C07K14/005 , C07K14/135 , C12N7/00 , C12N2760/18522 , C12N2760/18534
摘要: The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
-
公开(公告)号:US20080233150A1
公开(公告)日:2008-09-25
申请号:US11941768
申请日:2007-11-16
申请人: Gale SMITH , Peter Pushko , Mike Massare , Yingyun Wu , Kutub Mahmood
发明人: Gale SMITH , Peter Pushko , Mike Massare , Yingyun Wu , Kutub Mahmood
IPC分类号: A61K39/155 , A61P31/12 , C07K16/00
CPC分类号: A61K39/155 , A61K39/12 , A61K2039/5258 , C07K14/005 , C12N2760/18522 , C12N2760/18523 , C12N2760/18534 , Y02A50/386 , Y02A50/388 , Y02A50/394
摘要: The present invention discloses and claims virus like particles (VLPs) that express and/or contains RSV proteins. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing immunity to infections, including RSV.
摘要翻译: 本发明公开并要求表达和/或含有RSV蛋白质的病毒样颗粒(VLP)。 本发明包括包含所述蛋白质的载体构建体,包含所述构建体的细胞,制剂和包含本发明的VLP的疫苗。 本发明还包括制备和施用VLP到脊椎动物的方法,包括诱导感染免疫的方法,包括RSV。
-
公开(公告)号:US20120207786A1
公开(公告)日:2012-08-16
申请号:US13297125
申请日:2011-11-15
申请人: Gale SMITH , Rick Bright , Peter Pushko , Jinyou Zhang , Kutub Mahmood
发明人: Gale SMITH , Rick Bright , Peter Pushko , Jinyou Zhang , Kutub Mahmood
IPC分类号: A61K39/145 , A61P31/16
CPC分类号: A61K39/145 , A61K39/12 , A61K39/39 , A61K2039/5258 , A61K2039/543 , A61K2039/55505 , A61K2039/55555 , A61K2039/70 , C07K14/005 , C12N7/00 , C12N15/86 , C12N2710/14143 , C12N2760/16023 , C12N2760/16034 , C12N2760/16071 , C12N2760/16122 , C12N2760/16123 , C12N2760/16134
摘要: The present invention discloses and claims virus like particles (VLPs) that express and/or contains seasonal influenza virus proteins, avian influenza virus proteins and/or influenza virus proteins from viruses with pandemic potential. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing substantial immunity to either seasonal and avian influenza, or at least one symptom thereof.
摘要翻译: 本发明公开并要求从具有大流行潜力的病毒中表达和/或含有季节性流感病毒蛋白,禽流感病毒蛋白和/或流感病毒蛋白质的病毒样颗粒(VLPs)。 本发明包括包含所述蛋白质的载体构建体,包含所述构建体的细胞,制剂和包含本发明的VLP的疫苗。 本发明还包括制备和施用VLP到脊椎动物的方法,包括诱导季节性和禽流感的实质性免疫或其至少一种症状的方法。
-
5.
公开(公告)号:US20100143406A1
公开(公告)日:2010-06-10
申请号:US12306965
申请日:2007-06-27
申请人: Gale SMITH , Peter Pushko
发明人: Gale SMITH , Peter Pushko
CPC分类号: C07K14/005 , A61K2039/5258 , C07K2319/02 , C07K2319/03 , C12N2710/14143 , C12N2740/16122 , C12N2760/16122 , C12N2810/6054
摘要: The present invention comprises a method of increasing glycoprotein incorporation on the surface of VLPs, comprising expressing a nucleic acid encoding a chimeric glycoprotein in a host cell, wherein said chimeric glycoprotein comprises the transmembrane domain of an influenza hemagglutinin protein. The invention also embodies specific VLPs comprising said chimeric glycoproteins and methods of inducing immunity in an animal utilizing said VLPs.
摘要翻译: 本发明包括增加VLP表面上糖蛋白掺入的方法,包括在宿主细胞中表达编码嵌合糖蛋白的核酸,其中所述嵌合糖蛋白包含流感血凝素蛋白的跨膜结构域。 本发明还体现了包含所述嵌合糖蛋白的特异性VLP和利用所述VLP在动物中诱导免疫的方法。
-
公开(公告)号:US20100035813A1
公开(公告)日:2010-02-11
申请号:US12509033
申请日:2009-07-24
申请人: Gale SMITH , Peter Pushko , Vittoria Cioce
发明人: Gale SMITH , Peter Pushko , Vittoria Cioce
CPC分类号: C07K14/70564 , A61K38/00
摘要: The inventive features include recombinant mammalian E-selectin peptides, nucleic acids encoding said peptides, vectors and cells having these nucleic acids, and methods of making the peptides. Further inventive features include methods of treating diseases and conditions associated with inflammation using recombinant mammalian E-selectin peptides to induce mucosal tolerance to E-selectin.
摘要翻译: 本发明的特征包括重组哺乳动物E-选择蛋白肽,编码所述肽的核酸,具有这些核酸的载体和细胞,以及制备肽的方法。 其它发明特征包括使用重组哺乳动物E-选择蛋白肽治疗与炎症相关的疾病和病症以诱导对E-选择素的粘膜耐受的方法。
-
-
-
-
-